Medindia

X

Indian Pharmaceutical Company Soon to Register for a New Drug With USFDA

by Reshma Anand on  July 31, 2015 at 2:19 PM Corporate News   - G J E 4
Sun Pharma soon to file an application for a new drug with USFDA in two to three years, said Mr.Dilip Shanghvi, Managing director.
Indian Pharmaceutical Company Soon to Register for a New Drug With USFDA
Indian Pharmaceutical Company Soon to Register for a New Drug With USFDA
Advertisement

The firm's research arm SPARC (Sun Pharma Advanced Research Company) is currently working on three new drugs that are currently under clinical trial stage, he added.

Advertisement
"A few years back, we decided to separate our innovative business in a company called SPARC. That company has now three products undergoing clinical trials. And hopefully in the next two to three years, we should have our own new product registered in the US," said Shanghvi.

He, however, did not elaborate on the therapeutic areas on which those three chemical entities are under research.

The company has around 1,800 research scientists working in multiple R&D centers with expertise in developing generics, difficult to make technology intensive products, Active Pharmaceutical Ingredients (APIs), Novel Drug Delivery Systems (NDDS) and New Chemical Entities (NCEs). The company spends about 6 percent of its revenues on Research and Development.



Source: PTI
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All